Hepatic failure is a common critical condition caused by severe liver dysfunction, particularly acute (subacute) liver failure and subacute liver failure, which progress rapidly and have a high mortality rate. The basic principle of the artificial liver support system is to temporarily replace part of the liver’s function through extracorporeal mechanical, physicochemical, and biological devices, … Read more
Introduction Antibody-drug conjugates (ADC) are formed by linking monoclonal antibodies targeting specific antigens with small molecule cytotoxic drugs through linkers, combining the powerful killing effect of traditional small molecule chemotherapy with the tumor targeting ability of antibody drugs. Since ADCs first entered clinical trials in the mid-1990s, they have developed into a very successful oncology … Read more
Focused and dedicated, stepping onto the international stage Written by|Little Medicine Monster The latest generation of anti-HER-2 ADC drug developed by Hengrui, SHR-A1811, is often jokingly referred to as the domestic alternative to DS-8201 due to its similar structure. However, strength will eliminate all rumors. Results from early clinical studies released by AACR this year … Read more